Pacira BioSciences (PCRX) Short Interest Ratio & Short Volume → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free PCRX Stock Alerts $29.40 +0.36 (+1.24%) (As of 02:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pacira BioSciences Short Interest DataCurrent Short Volume4,070,000 sharesPrevious Short Volume4,170,000 sharesChange Vs. Previous Month-2.40%Dollar Volume Sold Short$119.70 millionShort Interest Ratio / Days to Cover8.1Last Record DateMarch 15, 2024Outstanding Shares46,500,000 sharesPercentage of Shares Shorted8.75%Today's Trading Volume200,065 sharesAverage Trading Volume504,296 sharesToday's Volume Vs. Average40% Short Selling Pacira BioSciences ? Sign up to receive the latest short interest report for Pacira BioSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPCRX Short Interest Over TimePCRX Days to Cover Over TimePCRX Percentage of Float Shorted Over Time Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> Pacira BioSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20244,070,000 shares $119.70 million -2.4%N/A8.1 $29.41 2/29/20244,170,000 shares $123.93 million +5.8%N/A7.4 $29.72 2/15/20243,940,000 shares $116.86 million +1.0%N/A7.4 $29.66 1/31/20243,900,000 shares $127.10 million +4.6%N/A6.9 $32.59 1/15/20243,730,000 shares $120.18 million +6.9%N/A7 $32.22 12/31/20233,490,000 shares $117.75 million +7.4%N/A6.5 $33.74 Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/20233,250,000 shares $101.69 million -0.9%N/A5.8 $31.29 11/30/20233,280,000 shares $89.48 million +2.8%N/A6.7 $27.28 11/15/20233,190,000 shares $91.11 million -11.1%N/A6.4 $28.56 10/31/20233,590,000 shares $101.45 million -8.7%N/A7.5 $28.26 10/15/20233,930,000 shares $114.52 million +12.0%N/A7.7 $29.14 9/30/20233,510,000 shares $107.69 million -0.3%N/A6.5 $30.68 9/15/20233,520,000 shares $118.41 million -1.4%N/A6.8 $33.64 8/31/20233,570,000 shares $126.02 million -4.8%N/A6.3 $35.30 8/15/20233,750,000 shares $139.91 million +9.7%N/A6.6 $37.31 7/31/20233,420,000 shares $124.32 million -3.4%N/A5.9 $36.35 7/15/20233,540,000 shares $132.01 million -2.5%N/A6 $37.29 6/30/20233,630,000 shares $145.45 million -0.6%N/A6.3 $40.07 6/15/20233,650,000 shares $147.17 million +3.7%N/A6.6 $40.32 5/31/20233,520,000 shares $133.87 million +4.5%N/A6.6 $38.03 5/15/20233,370,000 shares $143.12 million +7.7%N/A5.9 $42.47 4/30/20233,130,000 shares $141.82 million +4.0%N/A5.4 $45.31 4/15/20233,010,000 shares $127.77 million No ChangeN/A5.5 $42.45 3/31/20233,010,000 shares $122.84 million -10.4%N/A5.6 $40.81 3/15/20233,360,000 shares $132.25 million -5.9%N/A6.1 $39.36 2/28/20233,570,000 shares $151.97 million No ChangeN/A6.1 $42.57 2/15/20233,570,000 shares $144.91 million -20.7%N/A6.6 $40.59 1/31/20234,500,000 shares $176.72 million -12.8%N/A8.6 $39.27 1/15/20235,160,000 shares $193.09 million +4.2%N/A9.9 $37.42 12/30/20224,950,000 shares $191.12 million +7.1%N/A9.9 $38.61 12/15/20224,620,000 shares $184.38 million -6.3%N/A10.1 $39.91 11/30/20224,930,000 shares $237.87 million -10.5%N/A12.6 $48.25 11/15/20225,510,000 shares $275.50 million +0.7%N/A14.4 $50.00 10/31/20225,470,000 shares $283.13 million +1.7%N/A15.3 $51.76 10/15/20225,380,000 shares $277.61 million +4.3%N/A15.3 $51.60 9/30/20225,160,000 shares $274.46 million +2.2%N/A13.9 $53.19 9/15/20225,050,000 shares $274.06 million +4.3%N/A12.7 $54.27 8/31/20224,840,000 shares $254.00 million +3.9%N/A11.3 $52.48 8/15/20224,660,000 shares $269.02 million +1.8%N/A10.7 $57.73 7/31/20224,580,000 shares $259.04 million -0.2%N/A9.7 $56.56Urgent: Protect Your Investments from a Chinese Invasion (Ad)An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> PCRX Short Interest - Frequently Asked Questions What is Pacira BioSciences' current short interest? Short interest is the volume of Pacira BioSciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 4,070,000 shares of PCRX short. Learn More on Pacira BioSciences' current short interest. What is a good short interest ratio for Pacira BioSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCRX shares currently have a short interest ratio of 8.0. Learn More on Pacira BioSciences's short interest ratio. Which institutional investors are shorting Pacira BioSciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacira BioSciences: HAP Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pacira BioSciences' short interest increasing or decreasing? Pacira BioSciences saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 4,070,000 shares, a decrease of 2.4% from the previous total of 4,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pacira BioSciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pacira BioSciences: Supernus Pharmaceuticals, Inc. (9.39%), OPKO Health, Inc. (31.17%), ALX Oncology Holdings Inc. (10.70%), ADC Therapeutics SA (1.72%), Atea Pharmaceuticals, Inc. (2.30%), Nektar Therapeutics (1.41%), Seres Therapeutics, Inc. (12.18%), Corcept Therapeutics Incorporated (22.65%), Perrigo Company plc (2.76%), MannKind Co. (13.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Pacira BioSciences stock? Short selling PCRX is an investing strategy that aims to generate trading profit from Pacira BioSciences as its price is falling. PCRX shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pacira BioSciences? A short squeeze for Pacira BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCRX, which in turn drives the price of the stock up even further. How often is Pacira BioSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCRX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Supernus Pharmaceuticals Short Interest Data OPKO Health Short Interest Data ALX Oncology Short Interest Data ADC Therapeutics Short Interest Data Atea Pharmaceuticals Short Interest Data Nektar Therapeutics Short Interest Data Seres Therapeutics Short Interest Data Corcept Therapeutics Short Interest Data Perrigo Short Interest Data MannKind Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCRX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy